Bill

Bill > S2032


RI S2032

RI S2032
Prohibits an insurance company from imposing any cost-sharing requirements for any diagnostic or supplemental breast examinations.


summary

Introduced
01/09/2026
In Committee
01/09/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

This act would prohibit an insurance company from imposing any cost-sharing requirements for any diagnostic or supplemental breast examinations. This act would take effect on January 1, 2027.

AI Summary

This bill, effective January 1, 2027, prohibits insurance companies, including those offering accident and sickness policies, nonprofit hospital and medical service corporations, and health maintenance organizations, from charging patients any out-of-pocket expenses, such as deductibles, coinsurance, or copayments, for diagnostic or supplemental breast examinations. Diagnostic breast examinations are defined as medically necessary tests used to investigate an abnormality found during screening or detected by other means, including mammography, MRI, or ultrasound. Supplemental breast examinations are defined as medically necessary screenings, such as MRI or ultrasound, performed when no abnormality is suspected but an individual has a higher risk due to personal or family medical history or other factors.

Committee Categories

Health and Social Services

Sponsors (10)

Last Action

Introduced, referred to Senate Health and Human Services (on 01/09/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...